TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/08 19:18 | 11/14/08 | ARYX | Aryx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simon Nicholas J III | MA | DT | P.d | 3,933 | 2.20 | 0 | 1,788 | 50 | 5,365 | I | |||||||||||||||
11/13/07 13:38 | 11/13/07 | ARYX | Aryx Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Simon Nicholas J III | MA | DT | P.d | 3,000 | 10.00 | 0 | 300 | 9 | 3,581 | M | |||||||||||||||
5/4/07 15:09 | 5/2/07 | VRUS | Pharmasset Inc | Health | Drug | Pharmaceutical Preparations | Simon Nicholas J III | MA | T | P.d | 2,500 | 9.00 | 0 | 278 | 17 | 1,928 | I | ||||||||||||||||
5/1/07 15:25 | 4/30/07 | PARD | Poniard Pharmaceuticals, Inc. | WA | Health | Diagn | In Vitro & In Vivo Diagnostic | Simon Nicholas J III | MA | DT | P | 5,697 | 6.33 | 0 | 900 | 15 | 6,858 | I | |||||||||||||||
10/21/04 15:52 | 10/20/04 | CTRX | Cotherix Inc | Health | BioPrd | Biological Products, (No Diag | Simon Nicholas J III | MA | DT | P.d | 3,328 | 6.00 | 0 | 555 | 16 | 3,999 | I | ||||||||||||||||
5/5/04 18:40 | 5/4/04 | BTRX | Barrier Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Simon Nicholas J III | MA | DT | P | 3,000 | 15.00 | 0 | 200 | 9 | 2,341 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |